Search results for "Cell Transformation"

showing 10 items of 180 documents

A retrospective clinicopathological study on oral lichen planus and malignant transformation: Analysis of 518 cases

2011

Objective: To investigate the epidemiological and clinical characteristics of a relatively large cohort of patients with oral lichen planus (OLP) from eastern China. Study design: A total of 518 patients with histologically confirmed OLP in a long-term follow-up period (6 months-21.5 years) were retrospectively reviewed in our clinic. Results: Of the 518 patients, 353 females and 165 males were identified. The average age at diagnosis was 46.3 years (range 9-81 years) with the buccal mucosa being the most common site (87.8%). At initial presentation, white lichen and red lichen was seen in 52.3% and 47.7% patients, respectively. Of these, 5 (0.96%) patients previously diagnosed clinically a…

AdultMalemedicine.medical_specialtyAdolescentOdontologíaBuccal mucosaMalignant transformationYoung Adultstomatognathic systemEpidemiologyOral and maxillofacial pathologymedicineHumansYoung adultChildGeneral DentistryAgedRetrospective StudiesAged 80 and overOral Medicine and Pathologybusiness.industryCancerRetrospective cohort studyMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseCiencias de la saludDermatologySurgerystomatognathic diseasesCell Transformation NeoplasticOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASFemaleResearch-ArticleSurgeryOral lichen planusbusinessLichen Planus OralMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Small-Bowel Diagnosis in Patients with Familial Adenomatous Polyposis: Comparison of Push Enteroscopy, Capsule Endoscopy, Ileoscopy, and Enteroclysis

2009

BACKGROUND: Conventional upper endoscopy (EGD), EGD with side-view endoscope and ileoscopy are established procedures for endoscopic evaluation of patients with familial adenomatous polyposis (FAP). However, we still have little data on the frequency and relevance of adenomas in those parts of the small bowel which are not accessible to EGD and ileoscopy. Adenomas distal to the duodenum are found more often in FAP patients with known duodenal adenomas. The question is, whether these patients can benefit from additional endoscopic and/or radiographic examinations. METHODS: Between July 2001 and August 2006 we performed comparative small bowel studies with push enteroscopy (PE), capsule endos…

AdultMalemedicine.medical_specialtyAdolescentendocrine system diseasesEndoscopeDuodenumBiopsyRadiographyContrast MediaCapsule EndoscopySensitivity and SpecificityGastroenterologyEndoscopy GastrointestinalFamilial adenomatous polyposislaw.inventionYoung AdultCapsule endoscopylawInternal medicineIntestine SmallmedicinePush enteroscopyHumansIn patientIntubation GastrointestinalAgedbusiness.industryGastroenterologyMiddle Agedmedicine.diseasedigestive system diseasesstomatognathic diseasesCell Transformation NeoplasticJejunummedicine.anatomical_structureAdenomatous Polyposis ColiDuodenumFemaleBarium SulfatePouchbusinessZeitschrift für Gastroenterologie
researchProduct

Survival study of leukoplakia malignant transformation in a region of northern Spain

2017

Background Oral leukoplakia is the most common potentially malignant disorder (PMD) of the oral cavity. The objectives of this study are to determine the clinicopathologic features in a group of patients with oral leukoplakia of Northern Spain (Galicia), determining the factors associated to clinical risk and analyzing the malignant transformation of these patients. Material and Methods We included 85 patients. We recorded sex and age, habits like alcohol and tobacco, size, clinical appearance, site, number of lesions, and presence or absence of dysplasia. We assess the association between risk factors and transformation and developed a logistic regression analysis. Finally we used the Kapl…

AdultMalemedicine.medical_specialtyGastroenterologyMalignant transformationYoung Adult03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicineOral and maxillofacial pathologyCarcinomaHumansMedicineRisk factorGeneral DentistrySurvival rateSurvival analysisAgedLeukoplakiaAged 80 and overOral Medicine and Pathologybusiness.industryResearch030206 dentistryMiddle Aged:CIENCIAS MÉDICAS [UNESCO]medicine.diseaseSurvival Ratestomatognathic diseasesCell Transformation NeoplasticOtorhinolaryngologySpainDysplasia030220 oncology & carcinogenesisUNESCO::CIENCIAS MÉDICASFemaleSurgeryLeukoplakia OralbusinessMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

Monocyte Chemoattractant Protein-1 Serum Levels in Patients with Breast Cancer

2003

The chemokine monocyte chemoattractant protein (MCP)-1 is thought to be involved in breast carcinogenesis. We evaluated MCP-1 serum levels in patients with breast cancer (n = 135), ductal carcinoma in situ (DCIS) I-III (n = 30), benign breast lesions (n = 143) and in healthy women (n = 27). We determined the value of MCP-1 serum levels as a differentiation marker between malignant, preinvasive and benign breast diseases and as a predictive marker for the biological phenotype of breast carcinoma. Median (range) MCP-1 serum levels in patients with breast cancer, DCIS I-III, benign breast lesions and healthy women were 200 (57-692) pg/ml, 194 (58-525) pg/ml, 174 (39-529) pg/ml and 175 (67-425)…

AdultOncologymedicine.medical_specialtyCA 15-3Breast NeoplasmsBreast DiseasesBreast cancerReference ValuesInternal medicineBiomarkers TumormedicineCarcinomaHumansNeoplasm Invasivenessskin and connective tissue diseasesLymph nodeChemokine CCL2AgedRetrospective StudiesPredictive markerbusiness.industryCase-control studyGeneral MedicineMiddle AgedDuctal carcinomamedicine.diseaseCarcinoma Intraductal NoninfiltratingCell Transformation NeoplasticPhenotypemedicine.anatomical_structureCase-Control StudiesLymphatic MetastasisFemaleBreast carcinomabusinessTumor Biology
researchProduct

A polymorphism of the interleukin-1 receptor antagonist plays a prominent role within the interleukin-1 gene cluster in vulvar carcinogenesis

2003

Abstract Objective . The interleukin-1 (IL-1) family, that is, IL-1α and β and the IL-1 receptor antagonist (IL-1RA), is known to modulate various tumorgenic and tumorcidal effects in humans. Its biological function in squamous cell carcinogenesis of various anatomical sites has been stressed. Although various studies showed a certain association between genes encoding the IL-1 family and human malignancies, no data with respect to vulvar cancer have been published to date. Methods . We ascertained four polymorphisms of the IL-1α gene ( IL1A C[−889]T), the IL-1β gene ( IL1B promoter C[-511]T and IL1B exon 5 position +3953), and the IL-1RA gene ( IL1RN intron 2) in 68 patients with surgicall…

AdultSialoglycoproteinsBiologyBioinformaticsmedicine.disease_causePolymerase Chain ReactionExonGene clustermedicineHumansPromoter Regions GeneticAllelesAgedNeoplasm StagingAged 80 and overVulvar neoplasmPolymorphism GeneticVulvar NeoplasmsObstetrics and GynecologyInterleukinExonsMiddle AgedVulvar cancermedicine.diseaseInterleukin 1 Receptor Antagonist ProteinCell Transformation NeoplasticInterleukin 1 receptor antagonistOncologyIL1AMultigene FamilyCarcinoma Squamous CellCancer researchFemaleCarcinogenesisInterleukin-1Gynecologic Oncology
researchProduct

Peritoneal sarcomatosis 5 years after laparoscopic morcellation of uterine leiomyoma.

2017

In 2011, a 40-year-old woman underwent laparoscopic myomectomy with intraabdominal morcellation. Histology report showed leiomyoma without atypia, necrosis, or mitosis. In 2016, she complained of left lower quadrant pain; ultrasound examination revealed a left hypogastric mass in the site of trocar placement. Percutaneous biopsy results showed a low-grade endometrial stromal sarcoma (LGESS). At laparoscopy, we observed: multiple nodules on uterine serosa, left annex, vesical peritoneum (Figure 1), Douglas pouch (Supplementary Video1), previous left pelvic trocar site (Figure 2), greater omentum (Figure 3), and right/left diaphragm.

Adultmedicine.medical_specialtymedicine.medical_treatmentSarcoma Endometrial StromalMorcellationAnastomosisHysterectomyDouglas' Pouch03 medical and health sciences0302 clinical medicineUterine MyomectomyUterine NeoplasmmedicineHumansEndometrial Neoplasm030212 general & internal medicinePeritoneal Neoplasms030219 obstetrics & reproductive medicineUterine leiomyomaHysterectomyLeiomyomabusiness.industryAnastomosis SurgicalRectumObstetrics and GynecologySarcomatosismedicine.diseaseUterine myomectomySurgeryEndometrial NeoplasmsCell Transformation NeoplasticUterine NeoplasmsFemaleSarcomabusinessPeritoneal NeoplasmOmentumHumanAmerican journal of obstetrics and gynecology
researchProduct

Proteasome-inhibited dendritic cells demonstrate improved presentation of exogenous synthetic and natural HLA-class I peptide epitopes.

2004

The design and successful clinical implementation of cancer vaccines targeting the induction of T-cell mediated immunity is a rapidly evolving field that is hampered by an empirical selection of antigen and adjuvant. In particular, vaccines using defined tumor-associated peptide epitopes elicit only a restricted T-cell repertoire in a minority of patients. In this regard, vaccines comprising the whole spectrum of antigens presented by individual autologous tumors would be advantageous. In an in vitro model, we evaluated the capacity of naturally processed Epstein-Barr virus-transformed B-lymphoblastoid-cell line (LCL)-derived peptides to activate virus-specific CD8+ T cells of seropositive …

AntigenicityHerpesvirus 4 HumanT cellImmunologyHuman leukocyte antigenBiologyCD8-Positive T-LymphocytesIn Vitro TechniquesLymphocyte ActivationCancer VaccinesEpitopeMonocytesEpitopesAntigenHLA AntigensmedicineImmunology and AllergyHumansProtease InhibitorsAntigen PresentationImmunogenicityHistocompatibility Antigens Class IDendritic cellDendritic CellsCell Transformation ViralMolecular biologyCell biologyClone Cellsmedicine.anatomical_structureProteasome inhibitorLymphocyte Culture Test MixedProteasome Inhibitorsmedicine.drugJournal of immunological methods
researchProduct

CD2-mediated autocrine growth of herpes virus saimiri-transformed human T lymphocytes.

1992

Herpes virus saimiri (HVS) immortalizes T lymphocytes from a variety of primates and causes acute T cell lymphomas and leukemias in nonnatural primate hosts. Here we have analyzed the requirements for growth of three HVS-transformed human T cell lines. The cells expressed the phenotype of activated T cells: two were CD4+, and one was CD8+. All three cells responded to all allogeneic human cell lines tested with enhanced proliferation, production of interleukin 2 (IL-2), and increased expression of the IL-2 receptor. Binding of CD2 to its ligand CD58 was the critical event mediating stimulation because: (a) monoclonal antibodies (mAbs) to CD2 and to CD58, but not to a variety of other surfac…

Antigens Differentiation T-LymphocyteT-LymphocytesT cellImmunologyCD2 AntigensBiologyLymphocyte ActivationHerpesvirus 2 SaimiriineInterleukin 21medicineHumansImmunology and AllergyCytotoxic T cellIL-2 receptorReceptors ImmunologicAntigen-presenting cellInterleukin 3ArticlesCell Transformation ViralNatural killer T cellVirologyMolecular biologyPhenotypemedicine.anatomical_structureInterleukin 12Interleukin-2Cell DivisionJournal of Experimental Medicine
researchProduct

Herpes virus saimiri-transformed human T lymphocytes: normal functional phenotype and preserved T cell receptor signalling

1993

Herpes virus saimiri (HVS), a primate herpes virus, transforms human CD4+ and CD8+ T lymphocytes to continuous growth in vitro. We have previously shown that HVS-transformed human T cells (HVS-T cells) respond to stimulation via CD2 with autocrine growth. In the present study we have investigated the functional characteristics of HVS-T cells. We describe that these cells can perform all the functions of normal T cells, i.e. cytokine secretion, cytotoxicity, and exocytosis of granule esterases. All these activities can be triggered via CD2 by binding to its natural ligand or via the TCR, e.g. by anti-TCR antibodies, by recognition of a bacterial superantigen and by MHC-restricted recognition…

Antigens Differentiation T-LymphocyteT-Lymphocytesmedicine.medical_treatmentImmunologyCD2 AntigensReceptors Antigen T-Cellchemical and pharmacologic phenomenaBiologyLymphocyte ActivationHerpesvirus 2 SaimiriineTCIRG1AntigenmedicineHumansImmunology and AllergyCytotoxic T cellAntigensReceptors ImmunologicCell Line TransformedT-cell receptorGeneral MedicineT lymphocyteCell Transformation ViralVirologyCell biologyPhenotypeCytokineInterleukin-2Cytokine secretionCD8International Immunology
researchProduct

The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state

2012

AbstractMiR-125b-1 maps at 11q24, a chromosomal region close to the epicenter of 11q23 deletions in chronic lymphocytic leukemias (CLLs). Our results establish that both aggressive and indolent CLL patients show reduced expression of miR-125b. Overexpression of miR-125b in CLL-derived cell lines resulted in the repression of many transcripts encoding enzymes implicated in cell metabolism. Metabolomics analyses showed that miR-125b overexpression modulated glucose, glutathione, lipid, and glycerolipid metabolism. Changes on the same metabolic pathways also were observed in CLLs. We furthermore analyzed the expression of some of miR-125b–target transcripts that are potentially involved in the…

Blotting WesternImmunologyBiologyReal-Time Polymerase Chain ReactionBiochemistryNODownregulation and upregulationmicroRNABiomarkers TumorHumansMetabolomicsRNA MessengerPsychological repressionCells CulturedCell ProliferationOligonucleotide Array Sequence AnalysisRegulation of gene expressionB-LymphocytesLymphoid NeoplasiaReverse Transcriptase Polymerase Chain ReactionCell growthGene Expression ProfilingCell BiologyHematologyLeukemia Lymphocytic Chronic B-CellMolecular biologyGene Expression Regulation NeoplasticGene expression profilingMicroRNAsMetabolic pathwayCell Transformation NeoplasticChromosomal regionCancer researchBlood
researchProduct